{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T20:23:21Z","timestamp":1792355001324,"version":"4.4.0"},"publisher-location":"Chichester, UK","reference-count":153,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001949.pub2","type":"reference-entry","created":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T14:37:15Z","timestamp":1183473435000},"source":"Crossref","is-referenced-by-count":9,"title":["Pimozide for schizophrenia or related psychoses"],"prefix":"10.1002","author":[{"given":"John","family":"Rathbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"McMonagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,7,18]]},"reference":[{"key":"10.1002\/14651858.CD001949.pub2-BIB3|cit1","first-page":"547","article-title":"Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl","volume":"24","author":"Abuzzahab","year":"1980","journal-title":"Advances in Biochemistry and Psychopharmacology"},{"key":"10.1002\/14651858.CD001949.pub2-BIB2|cit2","first-page":"71","article-title":"Evaluations of social functioning in a 3-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia","volume":"13","author":"Abuzzahab","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD001949.pub2-BIB1|cit3","first-page":"26","article-title":"A three-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia","volume":"12","author":"Abuzzahab","year":"1976","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD001949.pub2-BIB4|cit4","first-page":"15","article-title":"A standard (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients","volume":"13","author":"Amin-MM","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD001949.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0447.1974.tb08043.x","article-title":"A controlled trial of pimozide and trifluoperazine in chronic schizophrenic syndromes","volume":"249","author":"Andersen","year":"1974","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD001949.pub2-BIB6|cit6","first-page":"17","article-title":"Clinical trial of pimozide","volume":"3","author":"Anumonye","year":"1976","journal-title":"West African Journal of Pharmacology and Drug Research"},{"key":"10.1002\/14651858.CD001949.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00583530","article-title":"Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenics","volume":"18","author":"Barnes","year":"1983","journal-title":"Social Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB8|cit8","first-page":"598","article-title":"Pimozide in the treatment of chronic schizophrenic patients","volume":"12","author":"Chouinard","year":"1970","journal-title":"Current Therapeutic Research and Clinical Experience"},{"key":"10.1002\/14651858.CD001949.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00430747","article-title":"Pimozide in the treatment of newly admitted schizophrenic patients","volume":"76","author":"Chouinard","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD001949.pub2-BIB10|cit10","first-page":"1005","article-title":"A double blind comison of pimozide vs. trifluoperazine in schizophrenic outpatients","volume":"16","author":"Claghorn","year":"1974","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001949.pub2-BIB12|cit11","unstructured":"Clark Pimozide vs thioridazine vs placebo Early Clinical Drug Evaluation Unit Reports 1973"},{"key":"10.1002\/14651858.CD001949.pub2-BIB11|cit12","first-page":"137","article-title":"Pimozide in chronic Schizophrenic outpatients","volume":"36","author":"Clark","year":"1975","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD001949.pub2-BIB13|cit13","first-page":"47","article-title":"Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up","volume":"76","author":"Denijs","year":"1973","journal-title":"Psychiatria Neurologia Neurochirurgia"},{"key":"10.1002\/14651858.CD001949.pub2-BIB14|cit14","first-page":"119","article-title":"Pimozide versus fluphenazine in ambulatory schizophrenics: a 12-month comparison study","volume":"38","author":"Donlon","year":"1977","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD001949.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S0033291700006632","article-title":"A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia","volume":"8","author":"Falloon","year":"1978","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD001949.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0033291700014318","article-title":"The social outcome of patients in a trial of long-term continuation therapy","volume":"8","author":"Falloon","year":"1978","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD001949.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0364-7722(79)90050-X","article-title":"Medico-social evaluation of the long term pharmacotherapy of schizophrenia. Comparitive study of fluphenazine and pimozide","volume":"3","author":"Shepherd","year":"1979","journal-title":"Progressive Neuro-Psychopharmacology"},{"key":"10.1002\/14651858.CD001949.pub2-BIB18|cit18","first-page":"487","article-title":"Pimozide (R6238) in chronic Schizophrenia: double blind trial","volume":"78","author":"Gowardman","year":"1973","journal-title":"New Zealand Medical Journal"},{"key":"10.1002\/14651858.CD001949.pub2-BIB19|cit19","first-page":"696","article-title":"A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients","volume":"16","author":"Gross-HS","year":"1974","journal-title":"Current Therapeutic Research and Clinical Experience"},{"key":"10.1002\/14651858.CD001949.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-2007-1019512","article-title":"Pimozide versus Haloperidol in acute schizphrenia. A double blind controlled study","volume":"15","author":"Haas","year":"1982","journal-title":"Pharmacopsychiatria"},{"key":"10.1002\/14651858.CD001949.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/009127007101100410","article-title":"Pimozide in chronic Schizophrenic patients","volume":"11","author":"Huber","year":"1971","journal-title":"Journal of Clinical Pharmacology and New Drugs"},{"key":"10.1002\/14651858.CD001949.pub2-BIB22|cit22","first-page":"768","article-title":"Comparison of pimozide and trifluoperazine as once-daily therapy in chronic Schizophrenic outpatients","volume":"21","author":"Kline","year":"1977","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001949.pub2-BIB23|cit23","first-page":"998","article-title":"A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients","volume":"16","author":"Kolivakis","year":"1974","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001949.pub2-BIB25|cit24","first-page":"685","article-title":"A double blind comparison of pimozide with carpipramine in schizophrenic patients","volume":"72","author":"Kudo","year":"1972","journal-title":"Acta Psychiatrica Belgica"},{"issue":"11","key":"10.1002\/14651858.CD001949.pub2-BIB24|cit25","first-page":"726","article-title":"The double-blind study of pimozide for schizophrenia","volume":"82","author":"Kudo","year":"1972","journal-title":"Igaku No Ayumi"},{"key":"10.1002\/14651858.CD001949.pub2-BIB26|cit26","first-page":"8","article-title":"A controlled pimozide, fluphenazine and group psychotherapy study of chronic schizophrenics","volume":"1","author":"Lapierre","year":"1976","journal-title":"Psychiatric Journal of the University of Ottawa"},{"issue":"6","key":"10.1002\/14651858.CD001949.pub2-BIB27|cit27","first-page":"655","article-title":"No English title available","volume":"10","author":"Masiak","year":"1976","journal-title":"Psychiatrica Poland"},{"key":"10.1002\/14651858.CD001949.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1192\/bjp.133.2.179","article-title":"Token economy, pimozide and chronic schizophrenia","volume":"133","author":"McCreadie","year":"1978","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.137.6.510","article-title":"Intermittent pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia","volume":"137","author":"McCreadie","year":"1980","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1192\/bjp.140.3.280","article-title":"Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia","volume":"140","author":"McCreadie","year":"1982","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1192\/S0007125000116691","article-title":"Weekly pimozide versus fluphenazine decanoate in schizophrenic out- and day-patients","volume":"143","author":"McCreadie","year":"1983","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1600-0447.1989.tb03032.x","article-title":"The Scottish first episode schizophrenia study. VII. Two-year follow up","volume":"80","author":"Wiles","year":"1989","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD001949.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1192\/bjp.161.4.496","article-title":"The Scottish first episode schizophrenia study. VIII. Five-year follow-up: clinical and psychosocial findings","volume":"161","year":"1992","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1192\/bjp.150.3.334","article-title":"The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol","volume":"150","year":"1987","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1192\/bjp.150.3.338","article-title":"The Scottish first episode schizophrenia study. III. Cognitive performance","volume":"150","year":"1987","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1192\/bjp.152.4.470","article-title":"The Scottish first episode schizophrenia study. One-year follow-up","volume":"152","year":"1988","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB37|cit37","first-page":"170","article-title":"The observer interaction variable in evaluation of socialising properties of pimozide (Orap)","volume":"87","author":"McInnes","year":"1978","journal-title":"New Zealand Medicine Journal"},{"key":"10.1002\/14651858.CD001949.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1192\/bjp.117.541.683","article-title":"A comparative double blind trial of pimozide and fluphenazine in chronic schizophrenia","volume":"117","author":"Morris","year":"1970","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0006-3223(85)90174-X","article-title":"Prophylactic effects of neuroleptics in symptom-free schizophrenics: roles of dopaminergic and noradrenergic blockers","volume":"20","author":"Nishikawa","year":"1985","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/070674378202700305","article-title":"Comparison of pimozide and chlorpromazine in acute schizophrenia","volume":"27","author":"Pecknold","year":"1982","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB41|cit41","series-title":"28 Nov-4 Dec 1971 World Congress of Psychiatry, Ciudad de Mexico","author":"Pinard","year":"1971"},{"key":"10.1002\/14651858.CD001949.pub2-BIB42|cit42","first-page":"22","article-title":"Pimozide: a comparative study in the treatment of chronic schizophrenic patients","volume":"6","author":"Pinard-G","year":"1972","journal-title":"International Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD001949.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0022-3956(84)90016-5","article-title":"The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol","volume":"18","author":"Silverstone","year":"1984","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD001949.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1017\/S0033291700056415","article-title":"Activity in chronic schizophrenic patients: comison of pimozide with fluphenazine in a double blind trial","volume":"5","author":"Sims","year":"1975","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD001949.pub2-BIB45|cit45","first-page":"17","article-title":"A standard (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients","volume":"13","author":"Vergara","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD001949.pub2-BIB46|cit46","first-page":"62","article-title":"Pimozide versus chlorpromazine in chronic schizophrenia - a 52-week double-blind study of maintenance therapy","volume":"43","author":"Wilson","year":"1982","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD001949.pub2-BIB47|cit47","first-page":"189","article-title":"Pimozide (R6238) Clinical tests with a new incisive neuroleptic of long lasting action","volume":"4","author":"Baggio","year":"1970","journal-title":"Revista Brasileira Psiquiatrica"},{"key":"10.1002\/14651858.CD001949.pub2-BIB48|cit48","first-page":"199","article-title":"Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment - a multidisciplinary approach","volume":"72","author":"Baro","year":"1972","journal-title":"Acta Psychiatrica Belgica"},{"key":"10.1002\/14651858.CD001949.pub2-BIB49|cit49","first-page":"137","article-title":"No English title available","volume":"68","author":"Bobon","year":"1968","journal-title":"Acta Neurologica Belgiana"},{"key":"10.1002\/14651858.CD001949.pub2-BIB50|cit50","first-page":"888","article-title":"No English title available","volume":"68","author":"DP","year":"1968","journal-title":"Acta Neurologica Belgiana"},{"key":"10.1002\/14651858.CD001949.pub2-BIB51|cit51","first-page":"875","article-title":"A multicentric clinical evaluation of pimozide. Preliminary report","volume":"68","author":"Brugmans","year":"1968","journal-title":"Acta Neurologica Psychiatrica Belgica"},{"key":"10.1002\/14651858.CD001949.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/j.1552-4604.1972.tb00032.x","article-title":"An international double-blind clinical evaluation of pimozide","volume":"12","author":"Janssen","year":"1972","journal-title":"Journal Clinical Pharmacology and New Drugs"},{"issue":"3","key":"10.1002\/14651858.CD001949.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"s325","DOI":"10.1016\/S0924-977X(00)80395-8","article-title":"Risperidone versus pimozide for the treatment of monosymptomatic hypochondriacal psychosis","volume":"10","author":"Cetin","year":"2000","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD001949.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1185\/03007997909109396","article-title":"Pimozide in the maintenance treatment of apathetic and emotionally withdrawn schizophrenics","volume":"6","author":"Cheadle","year":"1979","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD001949.pub2-BIB55|cit55","series-title":"132nd Annual Meeting of the American Psychiatric Association; 1979 May 12-18; Chicago, USA","article-title":"Pimozide in the treatment of acute schizophrenia","author":"Chouinard","year":"1979"},{"issue":"1","key":"10.1002\/14651858.CD001949.pub2-BIB56|cit56","first-page":"35","article-title":"Pimozide versus Placebo","volume":"7","author":"Clark","year":"1971","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD001949.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.148.2.120","article-title":"II. A randomised controlled trial of prophylactic neuroleptic treatment","volume":"148","author":"Crow","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB58|cit58","series-title":"10th European College of Neuropharmacology Congress 1997","first-page":"Vienna","article-title":"Does early treatment have an effect on outcome?","author":"Johnstone","year":"1997"},{"key":"10.1002\/14651858.CD001949.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1192\/bjp.148.2.128","article-title":"III. Short-term outcome in trial entrants and trial eligible patients","volume":"148","author":"MacMillan","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-0447.1974.tb08045.x","article-title":"Objective evaluation of EEG amplitude in chronic schizophrenic patients during a controlled trial of pimozide and trifluoperazine","volume":"249","author":"d'Elia","year":"1974","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD001949.pub2-BIB63|cit61","series-title":"Xth World Congress of Psychiatry, Madrid, Spain; August 23-28","article-title":"Levosulpiride vs Pimozide in Negative Symptoms of Schizophrenia","author":"Ronchi","year":"1996"},{"key":"10.1002\/14651858.CD001949.pub2-BIB61|cit62","series-title":"8th ECNP (European College of Neuropsychopharmacology) Congress, Venice, Italy","article-title":"Levosulpiride vs Pimozide in Negative Symptoms of Schizophrenia","author":"Ronchi"},{"key":"10.1002\/14651858.CD001949.pub2-BIB62|cit63","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0011-393X(96)80085-3","article-title":"Levosulpiride versus pimozide in negative symptoms of schizophrenia","volume":"57","author":"Ronchi","year":"1996","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"issue":"6","key":"10.1002\/14651858.CD001949.pub2-BIB64|cit64","first-page":"235","article-title":"Pimozide treatment of the negative schizophrenic syndrome: an open trial","volume":"49","author":"Feinberg","year":"1988","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0006-3223(97)00227-8","article-title":"Pimozide augmentation for the treatment of schizophrenic patients who are trial responders to clozapine","volume":"42","author":"Friedman","year":"199715","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD001949.pub2-BIB66|cit66","first-page":"389","article-title":"No English title available","volume":"96","author":"Frussa Filho","year":"1988","journal-title":"Farmacologia Clinica"},{"key":"10.1002\/14651858.CD001949.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1185\/03007997909109017","article-title":"Pimozide in acute schizophrenia: a pilot study","volume":"5","author":"Garton","year":"1979","journal-title":"Current Medical Research Opinion"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub2-BIB68|cit68","first-page":"83","article-title":"No English title available","volume":"22","author":"Gomez Perez","year":"1994","journal-title":"Actas Luso-Espanol Neurologia Psiquiatria"},{"issue":"8","key":"10.1002\/14651858.CD001949.pub2-BIB69|cit69","first-page":"888","article-title":"Pimozide and haloperidol in a double-blind study in acutely schizophrenic patients","volume":"32","author":"Haas","year":"1982","journal-title":"Arzneimittel Forschung"},{"key":"10.1002\/14651858.CD001949.pub2-BIB70|cit70","first-page":"138","article-title":"Nebenwirkungen von neuroleptika","volume":"11","author":"Holl","year":"1992","journal-title":"Nervenheeikunde"},{"key":"10.1002\/14651858.CD001949.pub2-BIB71|cit71","first-page":"604","article-title":"Long-term treatment of schizophrenia","volume":"78","author":"Huber","year":"1983","journal-title":"Medizinische Klinik"},{"key":"10.1002\/14651858.CD001949.pub2-BIB72|cit72","series-title":"10th World Congress of Psychiartry; 1996 Aug 23-28; Madrid","article-title":"Pimozide in the treatment of delusional disorder","author":"Ibarra","year":"1996"},{"key":"10.1002\/14651858.CD001949.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(88)90682-4","article-title":"The Northwick park \"functional\" psychosis study: diagnosis and treatment response","volume":"2","author":"Johnstone","year":"1988","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001949.pub2-BIB74|cit74","first-page":"69","article-title":"Pimozide compared with fluphenazine in schizophrenia","volume":"25","author":"Kenway","year":"1971","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD001949.pub2-BIB75|cit75","first-page":"67","article-title":"A double-blind comison of pimozide and haloperidol in the treatment of recurrent anxiety states","volume":"27","author":"Kenway","year":"1973","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD001949.pub2-BIB76|cit76","first-page":"359","article-title":"No English title available","volume":"23","author":"Konig","year":"1971","journal-title":"Psychiat. Neurol. med. Psychol"},{"issue":"3","key":"10.1002\/14651858.CD001949.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0733-8635(05)70379-X","article-title":"Psychopharmacology for dermatologic patients","volume":"14","author":"Koo","year":"1996","journal-title":"Dermatologic Clinics"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub2-BIB78|cit78","first-page":"68","article-title":"Pimozide versus Standards versus Placebo","volume":"7","author":"Krumholz","year":"1970","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD001949.pub2-BIB79|cit79","first-page":"181","article-title":"Pimozide and the social behavior of schizophrenics","volume":"18","author":"Lapierre","year":"1975","journal-title":"Current Therapeutic Research"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub2-BIB80|cit80","first-page":"61","article-title":"Pimozide versus Fluphenaine","volume":"7","author":"Lehmann","year":"1970","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD001949.pub2-BIB81|cit81","first-page":"45","article-title":"A double blind placebo controlled trial of Pimozide (R6238) on 49 hospitalized chronic schizophrenics","volume":"17","author":"Mahal","year":"1975","journal-title":"Indian Journal of Psychiatry"},{"issue":"suppl 2","key":"10.1002\/14651858.CD001949.pub2-BIB82|cit82","first-page":"49","article-title":"Pimozide (Orap): a multicentre study","volume":"7","author":"Marshall","year":"1971","journal-title":"Clinical Trials Journal"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/10401239209150446","article-title":"Rapid respose to pimozide in treatment resistant delusional disorder","volume":"4","author":"McCoy","year":"1992","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ddr.430090105","article-title":"Novel approaches to the pharmacotherapy of schizophrenia","volume":"9","author":"Meltzer","year":"1986","journal-title":"Drug Development Research"},{"key":"10.1002\/14651858.CD001949.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF02244775","article-title":"Negative symptoms in schizophrenia: considerations for clinical trials: working group on negative symptoms in schizophrenia","volume":"115","author":"Moller","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD001949.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/01454455970213004","article-title":"A review of cognitive behavioral and pharmacological treatment of body dysmorphic disorder","volume":"21","author":"Neziroglu","year":"1997","journal-title":"Behavioral Modification"},{"issue":"1","key":"10.1002\/14651858.CD001949.pub2-BIB87|cit87","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0010-440X(94)90165-1","article-title":"Psychopharmacologic treatment of negative symptoms","volume":"35","author":"LA","year":"1994","journal-title":"Comprehensive Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0193-953X(18)30061-3","article-title":"Pharmacologic treatment of delusions","volume":"18","author":"Opler","year":"1995","journal-title":"Psychiatr Clin North Am"},{"issue":"4","key":"10.1002\/14651858.CD001949.pub2-BIB89|cit89","first-page":"597","article-title":"Pharmacologic treatment of body dysmorphic disorder","volume":"32","author":"Phillips","year":"1996","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD001949.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0920-9964(96)00067-9","article-title":"Lack of gender differences in neuroleptic response in patients with schizophrenia","volume":"22","author":"Pinals","year":"1996","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD001949.pub2-BIB91|cit91","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000468208","article-title":"Application of the neuroleptic Pimozide (ORAP-R6238) for tranquilizer indications in a controlled study","volume":"11","author":"Poldinger","year":"1976","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1185\/03007997209111154","article-title":"A comative double-blind trial of pimozide in stress-induced psychic and functional disorders","volume":"1","author":"Reyntjens","year":"1972","journal-title":"Current Medical Research Opinion"},{"issue":"4","key":"10.1002\/14651858.CD001949.pub2-BIB93|cit93","first-page":"247","article-title":"A clinical study with pimozide in chronic schizophrenics","volume":"12","author":"Ruiz Ruiz","year":"1975","journal-title":"Revista de Psiquiatria y Psicologia Medica de Europa y America Latinas"},{"issue":"11","key":"10.1002\/14651858.CD001949.pub2-BIB94|cit94","first-page":"695","article-title":"Evaluation of clinical efficacy of pimozide as maintenance therapy in chronic schizophrenic patients","volume":"13","author":"Singh","year":"1971","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001949.pub2-BIB95|cit95","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-3956(74)90073-9","article-title":"A pilot study of pimozide in schizophrenia","volume":"11","author":"JR","year":"1974","journal-title":"Journal of Psychiatric Research"},{"issue":"12","key":"10.1002\/14651858.CD001949.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-4362.1994.tb01019.x","article-title":"Nature and treatment of delusional parasitosis: a different experience in India","volume":"33","author":"Srinivasan","year":"1994","journal-title":"International Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD001949.pub2-BIB97|cit97","first-page":"1107","article-title":"The clinical efficacy of pimozide in chronic psychotic patients","volume":"5","author":"Sterkmans","year":"1968","journal-title":"Clinical Trials Journal"},{"issue":"11","key":"10.1002\/14651858.CD001949.pub2-BIB98|cit98","first-page":"706","article-title":"A pilot study of pimozide in chronic schizophrenic patients","volume":"13","author":"Sugerman","year":"1971","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001949.pub2-BIB99|cit99","first-page":"93","article-title":"A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses","volume":"14","author":"Svestka","year":"1972","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD001949.pub2-BIB100|cit100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2007-1002227","article-title":"Therapeutische manahmen bei spaten extrapyramidalen hyperkineson","volume":"51","author":"Tegeler","year":"1983","journal-title":"Fortschr. Neurol. Psychiat"},{"issue":"3","key":"10.1002\/14651858.CD001949.pub2-BIB101|cit101","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00007611-199303000-00019","article-title":"Clinical uses of pimozide","volume":"86","author":"Teuth","year":"1993","journal-title":"Southern Medical Journal"},{"key":"10.1002\/14651858.CD001949.pub2-BIB102|cit102","first-page":"103","article-title":"Pimozide treatment for delusion of infestation","volume":"28","author":"Ungvari","year":"1986","journal-title":"Acta Nervosa Superior Praha"},{"key":"10.1002\/14651858.CD001949.pub2-BIB103|cit103","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.1982.04290030011002","article-title":"Antipsychotic effects of pimozide in schizophrenia. Treatment response prediction with acute dextroamphetamine response","volume":"39","author":"Kammen","year":"1982","journal-title":"Archive General Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB104|cit104","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000118403","article-title":"Effect of pimozide on positive and negative symptoms in schizophrenic patients: are negative symptoms state dependent?","volume":"18","author":"Kammen","year":"1987","journal-title":"Neuropsychobiology"},{"key":"10.1002\/14651858.CD001949.pub2-BIB105|cit105","first-page":"515","article-title":"Pimozide: an effective, once daily oral therapy for schizophrenia","volume":"46","author":"Wyk","year":"1972","journal-title":"South African Medical Journal"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001949.pub2-BIB106|cit106","first-page":"33","article-title":"Profile of the action of neuroleptics in deficit schizophrenia","volume":"22","author":"Vanelle","year":"1996","journal-title":"L'Encephale"},{"key":"10.1002\/14651858.CD001949.pub2-BIB107|cit107","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1017\/S0033291700048091","article-title":"The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment","volume":"13","author":"Watt","year":"1983","journal-title":"Psychological Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub2-BIB108|cit108","first-page":"113","article-title":"Differences in the clinical effects of various neuroleptics","volume":"XIV","author":"Welbel","year":"1980","journal-title":"Psychiatrica Poland"},{"issue":"6","key":"10.1002\/14651858.CD001949.pub2-BIB109|cit109","first-page":"859","article-title":"Levosulpiride vs Pimozide in schizophrenic patients: efficacy and adverse events","volume":"17","author":"Ronchi","year":"1997","journal-title":"Neurologia Psichiatria Scienze Umane"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub2-BIB110|cit110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3999\/jscpt.3.91","article-title":"A double-blind comparison of pimozide (r-6238) with chlorpromazine in chronic schizophrenia","volume":"3","author":"Umene","year":"1972","journal-title":"Rinsho Yakuri"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub2-BIB111|cit111","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000284.pub2","article-title":"Chlorpromazine versus placebo for schizophrenia","author":"Adams","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001949.pub2-BIB112|cit112","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001949.pub2-BIB113|cit113","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1192\/bjp.150.3.334","article-title":"The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group","volume":"150","author":"Anonymous","year":"1987","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB114|cit114","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001949.pub2-BIB115|cit115","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001949.pub2-BIB116|cit116","volume-title":"British National Formulary","volume":"35","year":"1998"},{"issue":"4","key":"10.1002\/14651858.CD001949.pub2-BIB117|cit117","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD001949.pub2-BIB118|cit118","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1943-278X.1992.tb01040.x","article-title":"Schizophrenia - a high-risk factor for suicide: clues to risk reduction","volume":"22","author":"Caldwell","year":"1992","journal-title":"Suicide and Life-Threatening Behavior"},{"issue":"Suppl","key":"10.1002\/14651858.CD001949.pub2-BIB119|cit119","first-page":"227","article-title":"Last observation carried forward in psychiatric research - a flawed gold standard?","volume":"81","author":"Cotton","year":"2006","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD001949.pub2-BIB120|cit120","first-page":"1","article-title":"Cardiotoxic effects of pimozide","volume":"29","year":"1990","journal-title":"Current problems"},{"key":"10.1002\/14651858.CD001949.pub2-BIB121|cit121","series-title":"Abstracts of 8th International Cochrane Colloquium","author":"Deeks J. Issues in the selection for meta-analyses of binary"},{"issue":"6","key":"10.1002\/14651858.CD001949.pub2-BIB122|cit122","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD001949.pub2-BIB123|cit123","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD001949.pub2-BIB124|cit124","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001949.pub2-BIB125|cit125","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD001949.pub2-BIB126|cit126","volume-title":"Early clinical drug evaluation (ECDEU) assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD001949.pub2-BIB127|cit127","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001949.pub2-BIB128|cit128","article-title":"Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]","volume-title":"Cochrane Library","volume":"3","author":"Higgins","year":"2005"},{"key":"10.1002\/14651858.CD001949.pub2-BIB129|cit129","volume-title":"ICD-10 Classification of mental and behavioral disorders","year":"1991"},{"key":"10.1002\/14651858.CD001949.pub2-BIB130|cit130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomised controlled trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD001949.pub2-BIB131|cit131","article-title":"Function and dysfunction of the basal ganglia","volume-title":"The rise of psychopharmacology and the story of CINP","author":"Janssen","year":"1998"},{"key":"10.1002\/14651858.CD001949.pub2-BIB132|cit132","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1192\/bjp.165.6.787","article-title":"Post-mortem antipsychotic drug concentrations and unexplained deaths","volume":"165","author":"Jusic","year":"1994","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB133|cit133","first-page":"487","article-title":"Other psychotic disorders","volume-title":"Synopsis of psychiatry","author":"Kaplan","year":"1994"},{"key":"10.1002\/14651858.CD001949.pub2-BIB134|cit134","first-page":"259","article-title":"Neuroleptics and schizophrenia","volume-title":"Seminars in clinical psychopharmacology","author":"King","year":"1995"},{"issue":"1","key":"10.1002\/14651858.CD001949.pub2-BIB135|cit135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/schbul\/sbl025","article-title":"Is the superior efficacy of new generation antipsychotics an artifact of LOCF?","volume":"33","author":"Leucht","year":"2007","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD001949.pub2-BIB136|cit136","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB137|cit137","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001949.pub2-BIB138|cit138","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001949.pub2-BIB139|cit139","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"Montgomery Asberg Depression Rating Scale","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB140|cit140","first-page":"34","article-title":"Monosymptomatic hypochondriacal psychosis","volume":"24","author":"Munro","year":"1980","journal-title":"British Journal of Hospital Medicine"},{"issue":"5","key":"10.1002\/14651858.CD001949.pub2-BIB141|cit141","first-page":"221","article-title":"The role of pimozide in clinical psychiatry","volume":"52","author":"Opler","year":"1991","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB142|cit142","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"issue":"2","key":"10.1002\/14651858.CD001949.pub2-BIB143|cit143","article-title":"Depot haloperidol decanoate for schizophrenia","author":"Quraishi","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001949.pub2-BIB144|cit144","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jama.1994.03520020051014","article-title":"Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals","volume":"272","author":"Schulz","year":"1994","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001949.pub2-BIB145|cit145","first-page":"408","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA 1995"},{"key":"10.1002\/14651858.CD001949.pub2-BIB146|cit146","volume-title":"Drug treatment in psychiatry","author":"Silverstone","year":"1995"},{"key":"10.1002\/14651858.CD001949.pub2-BIB147|cit147","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatria Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD001949.pub2-BIB148|cit148","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/schbul\/16.1.87","article-title":"The impact of substance abuse on the course and outcome of schizophrenia","volume":"16","author":"Turner","year":"1990","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD001949.pub2-BIB149|cit149","article-title":"Psychopharmacology in Argentina","volume-title":"The rise of psychopharmacology and the story of CINP","author":"Udabe","year":"1998"},{"issue":"5","key":"10.1002\/14651858.CD001949.pub2-BIB150|cit150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD001949.pub2-BIB151|cit151","volume-title":"The measurement and classification of symptoms","author":"Wing","year":"1974"},{"key":"10.1002\/14651858.CD001949.pub2-BIB152|cit152","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0010-440X(97)90001-8","article-title":"Delusional disorder (paranoia)","volume":"18","author":"Winokur","year":"1977","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD001949.pub2-BIB153|cit153","article-title":"Serotonin and obsessive compulsive disorder","volume-title":"The rise of psychopharmacology and the story of CINP","author":"Yaryura-Tobias","year":"1998"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001949.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T00:00:00Z","timestamp":1383609600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001949.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T18:18:12Z","timestamp":1708021092000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001949.pub2"}},"subtitle":[],"editor":[{"given":"John","family":"Rathbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,7,18]]},"references-count":153,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001949.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD001949.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2007,7,18]]}}}